Literature DB >> 8213525

Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.

J L Blackshear1, L A Pearce, R W Asinger, H C Dittrich, M E Goldman, M Zabalgoitia, R M Rothbart, J L Halperin.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8213525     DOI： 10.1016/0002-9149(93)91079-w

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  11 in total

1.  Service provision and use of anticoagulants in atrial fibrillation.

Authors:  C M Sudlow; H Rodgers; R A Kenny; R G Thomson
Journal:  BMJ       Date:  1995-08-26

Review 2.  Role of Echocardiography in the Management and Prognosis of Atrial Fibrillation.

Authors:  David I Silverman; Srilatha R Ayirala; Warren J Manning
Journal:  J Atr Fibrillation       Date:  2012-02-02

Review 3.  Stroke prevention in atrial fibrillation.

Authors:  R G Hart
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

4.  Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.

Authors:  G Y H Lip; L A Pearce; B S P Chin; D S G Conway; R G Hart
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

5.  Left atrial appendage functions in patients with severe rheumatic mitral regurgitation.

Authors:  Atila Bitigen; Mustafa Bulut; Ali C Tanalp; Cevat Kirma; Irfan Barutçu; Selcuk Pala; Ayhan Erkol; Bilal Boztosun
Journal:  Int J Cardiovasc Imaging       Date:  2007-02-13       Impact factor: 2.357

6.  Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation.

Authors:  S Dubrey; A Pollak; M Skinner; R H Falk
Journal:  Br Heart J       Date:  1995-11

7.  Transesophageal echocardiographic determinants of embolism in nonrheumatic atrial fibrillation.

Authors:  R Mitusch; V Lange; U Stierle; B Maurer; A Sheikhzadeh
Journal:  Int J Card Imaging       Date:  1995-03

Review 8.  Anti-thrombotic strategies for patients with atrial fibrillation and heart failure.

Authors:  Mary Norine Walsh; Eric N Prystowsky
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

9.  Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair.

Authors:  Ashwin S Nathan; Lin Yang; Zhi Geng; Elias J Dayoub; Sameed Ahmed M Khatana; Paul N Fiorilli; Howard C Herrmann; Wilson Y Szeto; Pavan Atluri; Michael A Acker; Nimesh D Desai; David S Frankel; Francis E Marchlinski; Alexander C Fanaroff; Jay Giri; Peter W Groeneveld
Journal:  Am Heart J       Date:  2020-10-24       Impact factor: 5.099

10.  Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.

Authors:  Günter Breithardt; Helmut Baumgartner; Scott D Berkowitz; Anne S Hellkamp; Jonathan P Piccini; Yuliya Lokhnygina; Jonathan L Halperin; Daniel E Singer; Graeme J Hankey; Werner Hacke; Richard C Becker; Christopher C Nessel; Kenneth W Mahaffey; Robert M Califf; Keith A A Fox; Manesh R Patel
Journal:  Heart       Date:  2016-02-17       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.